Details

Last Funding Type

Debt Financing

Last Funding Money Raised

$7M

Industries

Biotechnology,Health Diagnostics,Pharmaceutical

Founded date

Jan 1, 1996

Number Of Employee

11 - 50

Operating Status

Active

Inotek Pharmaceuticals is developing molecules with novel mechanisms of action to fulfill major unmet medical needs in significant diseases of the eye. Complete loss of vision or vision impairment currently affects 3.3 million people over the age of 40 in the United States, with the most common diseases including age-related macular degeneration (AMD), glaucoma, cataract and diabetic retinopathy. With the continued aging of the population, the National Eye Institute projects that this number will grow to 5.5 million people by the year 2020.